Hospital News and Research

RSS

EHR Association to help hospitals install and use electronic health records

The HIMSS Electronic Health Record Association (EHR Association) responded with enthusiasm to the announcement on August 20 of the availability of grants totaling nearly $1.2 billion to help hospitals and health care providers successfully install and use electronic health records (EHRs) as part of the continued implementation of the healthcare IT provisions of the American Recovery and Reinvestment Act of 2009 (ARRA).

27 Aug 2009

Inventor of the SPIDER Limb Positioner wins a $10,000 Manning Innovation Award

Calgary biomed engineer Brent King is to win a $10,000 Manning Innovation Award for inventing a unique device to accurately and securely position a surgical patient's limb.

27 Aug 2009

CDEX's Pay-Per-Use plan increases affordability of ValiMed medication safety technology

CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces the signing of two multi-unit contracts for the placement of four new ValiMed Units in U.S. hospitals. One of the contracts was for the direct purchase of two units and one contract was a two unit Pay-Per-Use pricing plan that CDEX recently implemented to allow more hospitals to afford this life saving medication safety technology.

27 Aug 2009

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide.

27 Aug 2009

Novelos Therapeutics enters into a definitive agreement with Purdue Pharma to raise funds

Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.

27 Aug 2009

Research study indicates that liver regeneration could affect the metabolism of tacrolimus in LDLT

Several studies have shown that living donor liver transplant (LDLT) recipients required smaller doses of tacrolimus compared with deceased donor liver transplant (DDLT) patients, which indicated that liver regeneration could affect the metabolism of tacrolimus in LDLT.

27 Aug 2009

Lawson to provide software suites to Oklahoma State University Medical Center

Oklahoma State University Medical Center, an osteopathic teaching hospital, was recently purchased from Ardent Health Services by a City of Tulsa trust. As part of the transition of management and operations, the trust launched a plan to improve business management and supply chain processes at Oklahoma State University Medical Center.

27 Aug 2009

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.

27 Aug 2009

Analysis of a pending health reform bill reveals that more 1,800 caregivers in Michigan may lose their jobs

An American Health Care Association (AHCA) analysis of a pending U.S. House health reform bill, HR 3200, finds seniors in Michigan requiring nursing and rehabilitative care will face funding cuts of $1.5 billion over the next 10 years. This equals the 10th highest state cut across the nation.

27 Aug 2009

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.

27 Aug 2009

Researchers find the method involved in setting up communications network of connections in the brain

In a new study, researchers at the Montreal Neurological Institute and Hospital (The Neuro), McGill University have found an important mechanism involved in setting up the vast communications network of connections in the brain.

27 Aug 2009

Iowa hospital pays Feds $4.5 million for overpaying doctors with Medicare money

An Iowa hospital has agreed to pay $4.5 million to the federal government to settle claims that it illegally overpaid physicians in an effort to boost business.

27 Aug 2009

Barrier-focused intervention program to increase colonoscopy attendance

In view of low attendance rate for colonoscopy screening for colorectal cancer (CRC), it is necessary to establish effective intervention methods to increase colonoscopy compliance. Many studies have reported that subjective or objective barriers prevent high-risk subjects from undergoing colonoscopy examination, which indicates that barrier-focused intervention might be effective. However, such barrier-focused intervention has not been reported in China.

27 Aug 2009

Alegro announces fiscal 2009 second-quarter results

Alegro Health Corp. (TSX-V: AGO), a healthcare services provider, today announced its financial results for the second quarter ended June 30, 2009.

27 Aug 2009

New technique for diabetes treatment may be in the offing

An exploration of the molecular links between insulin resistance and inflammation may have revealed a novel target for diabetes treatment, say scientists at the John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh of UPMC. Their findings were published earlier this month in the online version of Diabetes, one of the journals of the American Diabetes Association.

27 Aug 2009

BioAlliance Pharma's LIP phase III pivotal study provides positive preliminary results

BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.

27 Aug 2009

Angeion Corporation announces financial results for third-quarter fiscal 2009

For the 2009 third quarter, Angeion posted a net loss of $173,000, or $0.04 per diluted share, on revenues of $6.2 million. This represents a sequential improvement from a 2009 second-quarter net loss of $225,000, or $0.05 per diluted share, also on revenues of $6.2 million.

27 Aug 2009

DermaStream continuous streaming therapy for healing bedsores and chronic ulcers

More than six million people in the U.S. suffer from persistent wounds -- open sores that never seem to heal or, once apparently healed, return with a vengeance. The bedridden elderly and infirm are prone to painful and dangerous pressure ulcers, and diabetics are susceptible to wounds caused by a lack of blood flow to the extremities.

27 Aug 2009

Patients with Phenylketonuria face increased risk of developing severe neurological complications

Genetic researchers at Children's Memorial Hospital, Chicago, are aggressively identifying adult patients who suffer from the genetic disorder, Phenylketonuria (PKU), and are presenting those findings at the 11th International Congress of Inborn Errors of Metabolism in San Diego, August 29 through September 2.

26 Aug 2009

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

A new Web site, www.DeathRiskRankings.com, developed by researchers and students at Carnegie Mellon University, allows users to query publicly available data from the United States and Europe, and compare mortality risks by gender, age, cause of death and geographic region. The Web site not only gives the risk of dying within the next year, but it also ranks the probable causes and allows for quick side-by-side comparison between groups.

26 Aug 2009

Hospital News and Research

EHR Association to help hospitals install and use electronic health records

Inventor of the SPIDER Limb Positioner wins a $10,000 Manning Innovation Award

CDEX's Pay-Per-Use plan increases affordability of ValiMed medication safety technology

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Novelos Therapeutics enters into a definitive agreement with Purdue Pharma to raise funds

Research study indicates that liver regeneration could affect the metabolism of tacrolimus in LDLT

Lawson to provide software suites to Oklahoma State University Medical Center

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

Analysis of a pending health reform bill reveals that more 1,800 caregivers in Michigan may lose their jobs

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

Researchers find the method involved in setting up communications network of connections in the brain

Iowa hospital pays Feds $4.5 million for overpaying doctors with Medicare money

Barrier-focused intervention program to increase colonoscopy attendance

Alegro announces fiscal 2009 second-quarter results

New technique for diabetes treatment may be in the offing

BioAlliance Pharma's LIP phase III pivotal study provides positive preliminary results

Angeion Corporation announces financial results for third-quarter fiscal 2009

DermaStream continuous streaming therapy for healing bedsores and chronic ulcers

Patients with Phenylketonuria face increased risk of developing severe neurological complications

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News